Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced a set of strategic efforts designed to accelerate earlier recognition and improve care coordination ...

Healthcare treatment. Hospital preferences. End-of-life care. Some choices are too important to leave to chance—yet they often are. A recent poll found that only 46% of older adults in the U.S. had ...

HOUSTON--(BUSINESS WIRE)-- Today at Groundbreak 2025, Procore Technologies, Inc. (PCOR) (NYSE: PCOR), the leading global provider of construction management software, unveiled new AI capabilities ...

report by the National Academies of Sciences, Engineering, and Medicine. Although some malicious applications of synthetic biology may not seem plausible right now, they could become achievable with ...